Argus upgraded AbbVie (ABBV) to Buy from Hold with a $220 price target Two of the company’s key immunology products, Skyrizi and Rinvoq, have succeeded Humira as growth engines, with the former having ...

Cigna projected 2025 profit growth of at least 10% on Thursday, after posting quarterly results that beat Wall Street ...

Sees FY24 U.S Humira sales $7.4B, down $400M from prior view. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks ...

This current study seeks to identify these policies by comparing the US and EU prosecution histories of formulation patents covering Humira. The USPTO and EPO are counterpart authorities. They each ...

Large PBMs are removing Humira from some of their formularies. AMCP Nexus panelists still see challenges and a need for education and more attention to patient interests. Although there are now 10 ...